P a g e |1 Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically,

First Page		Document Content
Date: 2013-11-14 10:27:36 Pharmaceutical industry Clinical research Alternative cancer treatments Pharmacology Clinical Data Management Stanislaw Burzynski Antineoplaston Case report form Clinical trial Medicine Pharmaceutical sciences Research		P a g e \|1 Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically, Add to Reading List Source URL: www.burzynskiresearch.com Download Document from Source Website File Size: 915,05 KB Share Document on Facebook

	Meditating in peace on the coast DocID: 1r6Dg - View Document
	Breast Care MULTIDISCIPLINARY JOURNAL FOR RESEARCH, DIAGNOSIS AND THERAPY Personal View · Persönliche Meinung Breast Care 2009;4:31–33 DocID: 1q7W6 - View Document
	Newsletter SummerGUTSY GROUP Articles: The patients, surgeons, dieticians and medical team DocID: 1piiD - View Document
	THE ULTIMATE GUIDE TO VITAMIN B-17 METABOLIC THERAPY Published by Worldwithoutcancer.org.uk DocID: 1oOiF - View Document
	Unconventional Cancer Treatments DocID: 19e15 - View Document